Control of Hepatitis C: A Medicinal Chemistry Perspective
β Scribed by Christopher P. Gordon; Paul A. Keller
- Publisher
- John Wiley and Sons
- Year
- 2005
- Weight
- 8 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
For Abstract see ChemInform Abstract in Full Text.
π SIMILAR VOLUMES
Despite federal, state, and local public health efforts to prevent and control hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, these diseases remain serious health problems in the United States. About 1%-2% of the U.S. population has chronic HBV or HCV infections, and each year about
## Abstract Dopamine (DA) D~3~ receptor antagonism might play a significant role in different therapeutic areas. A high number of preclinical studies on DA D~3~ receptor antagonists have shown efficacy in animal models of Parkinsonβs disease, schizophrenia and drug dependence. This Review covers th
The present state of faculties, student bodies, and curricula in departments of medicinal chemistry have been surveyed by questionnaire and analyzed in the context of perceptions of quality and content. The results reveal a healthy diversity of educational objectives and a broader range of education